The Evolution of Coreceptor Tropism in HIV-infected Patients Interrupting Suppressive Antiretroviral Therapy

被引：13
|
作者：
Waters, Laura J. [1 ]
Scourfield, Andrew T. [1 ]
Marcano, Marie [1 ]
Gazzard, Brian G. [1 ]
Bower, Mark [1 ]
Nelson, Mark [1 ]
Stebbing, Justin [1 ]
机构：
[1] Chelsea & Westminster Hosp Fdn Trust, Dept Genitourinary HIV Med, London, England
来源：
CLINICAL INFECTIOUS DISEASES | 2011年 / 52卷 / 05期
关键词：
POPULATION; HAART;
D O I：
10.1093/cid/ciq198
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
CCR5 antagonists may provide a well-tolerated switch option for patients experiencing tolerability or toxicity of their antiretroviral regimen. We analyzed stored samples from patients undergoing planned treatment interruptions for reasons other than virological failure, in order to analyze tropism evolution during fully suppressive antiretroviral therapy (ART). Two of 37 patients showed evidence of switching. Tropism switching after suppressive ART was uncommon in this cohort. Pretreatment human immunodeficiency virus (HIV) RNA tropism testing may help guide the switch to CCR5 antagonists in patients with undetectable HIV RNA.
引用
收藏
页码：671 / 673
页数：3
相关论文
共 50 条
  • [41] Risk factors for proteinuria in HIV-infected patients on antiretroviral therapy
    Perez-Gonzalez, Y. S.
    Mata-Marin, J. A.
    ANTIVIRAL THERAPY, 2013, 18 : A82 - A82
  • [42] CHARACTERISTICS OF GRAVES DISEASE IN HIV-INFECTED PATIENTS ON ANTIRETROVIRAL THERAPY
    Jariyawattanarat, Vitvala
    Sungkanuparph, Somnuek
    Sriphrapradang, Chutintorn
    ENDOCRINE PRACTICE, 2020, 26 (06) : 612 - 618
  • [43] Parkinsonism in HIV-infected patients on highly active antiretroviral therapy
    Tisch, S.
    Brew, B. J.
    MOVEMENT DISORDERS, 2009, 24 : S425 - S425
  • [44] Management of dyslipidaemia in HIV-infected patients receiving antiretroviral therapy
    Martínez, E
    Tuset, M
    Milinkovic, A
    Miró, JM
    Gatell, JM
    ANTIVIRAL THERAPY, 2004, 9 (05) : 649 - 663
  • [45] Sexual hormones in HIV-infected patients: the influence of antiretroviral therapy
    Collazos, J
    Martinez, E
    Mayo, J
    Ibarra, S
    AIDS, 2002, 16 (06) : 934 - 937
  • [46] Pneumococcal pneumonia in HIV-infected patients by antiretroviral therapy periods
    Saindou, M.
    Chidiac, C.
    Miailhes, P.
    Voirin, N.
    Baratin, D.
    Amiri, M.
    Livrozet, J-M
    Touraine, J-L
    Trepo, C.
    Peyramond, D.
    Vanhems, P.
    HIV MEDICINE, 2008, 9 (04) : 203 - 207
  • [47] Heterogeneity of patients' adherence profile to antiretroviral therapy in HIV-infected patients
    Kennedy, BL
    O'Malley, J
    Khanlou, H
    Farthing, C
    JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES, 2001, 28 (03) : 307 - 308
  • [48] The effect of atorvastatin treatment on HIV-1-infected patients interrupting antiretroviral therapy
    Negredo, E
    Clotet, B
    Puig, J
    Pérez-Alvarez, N
    Ruiz, L
    Romeu, J
    Moltó, J
    Rey-Joly, C
    Blanco, J
    AIDS, 2006, 20 (04) : 619 - 621
  • [49] Envelope Coreceptor Tropism, Drug Resistance, and Viral Evolution Among Subtype C HIV-1-Infected Individuals Receiving Nonsuppressive Antiretroviral Therapy
    Kassaye, Seble
    Johnston, Elizabeth
    McColgan, Bryan
    Kantor, Raini
    Enah, Lynn Z.
    Katzenstein, David
    JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES, 2009, 50 (01) : 9 - 18
  • [50] Biomarkers of inflammation in HIV-infected Peruvian men and women before and during suppressive antiretroviral therapy
    Ticona, Eduardo
    Bull, Marta E.
    Soria, Jaime
    Tapia, Kenneth
    Legard, Jillian
    Styrchak, Sheila M.
    Williams, Corey
    Mitchell, Caroline
    Rosa, Alberto L. A.
    Coombs, Robert W.
    Frenkel, Lisa M.
    AIDS, 2015, 29 (13) : 1617 - 1622
12345